Abstract: A potential reduction in symptoms related to atrial fibrillation after treatment of gastroesophageal reflux disease symptoms with proton pump inhibitor therapy has been previously described. However, illustration of this relationship by combined 24-hour pH and ambulatory Holter monitoring has not been performed. We report 3 patients with symptoms of both palpitations and reflux who underwent simultaneous Holter and 24-hour ambulatory pH monitoring off of antireflux therapy. All of the patients reported a reduction in arrhythmia symptoms on proton pump inhibitor therapy. The findings from this preliminary series suggest a potential relationship between gastroesophageal reflux disease and atrial arrhythmias that might improve with antireflux therapy. Patients with documentation of both atrial arrhythmias and reflux should have a trial of aggressive acid suppressive therapy To further confirm this relationship, larger prospective studies are needed to assess whether maximal acid suppression improves arrhythmias.
B
oth gastroesophageal reflux disease (GERD) and atrial arrhythmias are common. GERD occurs in 7% of Americans on a daily basis, 14% on a weekly basis, 1 and 44% at least once a month. 2 Cardiac arrhythmias are also a frequent occurrence. Atrial fibrillation affects approximately 2.2 millions adults in the United States and is the most common sustained arrhythmia observed in clinical practice. 3 A potential reduction in symptoms related to atrial fibrillation after treatment of erosive esophagitis and GERD symptoms with proton pump inhibitor (PPI) therapy has been previously described. 4 However, illustration of this relationship by combined 24-hour pH and ambulatory Holter monitoring has not been performed. Our hypothesis was that the presence of pathologic GERD might precipitate atrial arrhythmias in patients reporting symptoms of both diseases. We report a case series of 3 patients with palpitations and gastroesophageal reflux symptoms who, upon simultaneous Holter and 24-hour esophageal pH monitoring, exhibited a temporal relationship between acid reflux episodes and atrial arrhythmias and subsequently reported a reduction of arrhythmic symptoms while on antisecretory drug therapy.
METHODS
All 3 patients had heartburn, acid-regurgitation, and palpitations occurring at least weekly and reported a potential association between the palpitations and GERD symptoms. None of the patients had significant coronary artery disease as documented by clinical and echocardiographic evaluation. Thyroid disease and any other potential metabolic causes for tachycardia were excluded. All patients had normal upper endoscopic examinations. The patients underwent simultaneous 24-hour esophageal ambulatory pH and Holter monitoring off of antireflux therapy for at least 7 days to investigate a potential relationship between GERD symptoms and the presence of cardiac arrhythmic events. We verified that the clocks were synchronized on both of the devices at the start of the studies so that we could analyze both studies for coordinated events.
Twenty-four-hour Ambulatory pH Monitoring
Twenty-four-hour intraesophageal pH monitoring was performed using a pH catheter connected to a portable digital recorder that stored pH data for up to 24 hours (Mark III, Medtronics, Inc, Minneapolis, MN). After calibration, the pH catheter was passed transnasally with its proximal sensor positioned 5 cm above the proximal margin of the lower esophageal sphincter previously determined by esophageal manometry. After the study, data were analyzed using special software (Medtronics, Inc, Minneapolis, MN). The components of a positive score require a percentage total time with distal esophageal pH<4.0 of 4.0% or greater, percentage upright pH<4.0 of at least 7.1%, and percentage supine pH<4.0 of 1.5% or more. 5 A reflux episode was defined as a drop in pH in the distal esophagus below 4.0 lasting longer than 15 seconds as defined by the Medtronics software. We did not exclude mealtimes from the analysis because the evidence for substantial influence of dietary factors on esophageal acid exposure is poor. 
Ambulatory Holter Monitoring
Twenty-four-hour continuous electrocardiographic (Holter) monitoring was performed using standard C5 and CM5 leads. Scanning of the tapes for areas of artifact and arrhythmia analysis was performed using Applied Cardiac Systems (Applied Cardiac Systems, Inc, Laguna Hills, CA).
Assessment of Correlation Between Reflux Episodes and Arrhythmia
We calculated the number of distal esophageal acid reflux episodes lasting longer than 15 seconds, and the percentage of such episodes that were symptomatic (associated with symptoms of heartburn or regurgitation). On the Holter study, we considered any episode of paroxysmal atrial arrhythmia (including atrial fibrillation, atrial flutter, other supraventricular tachycardias, or atrial-ventricular block) to be significant. For each arrhythmic or reflux event we recorded the duration and number of events that occurred per hour of the study.
To define a potential correlation between a reflux episode and an arrhythmic event, we considered 3 potential analytic methods. Our hypothesis was that the presence of GERD might trigger the onset of an atrial arrhythmia. The first analytic method examined the total time of arrhythmic and reflux events. Correlation between a pH episode and an arrhythmic event was defined as both events either occurring at the same time or if there was a reflux episode occurring 2 minutes before an arrhythmic event. We then compared the total amount of time in minutes that reflux episodes occurred with or without the presence of arrhythmic events.
For the second analysis, we used a previously published and widely accepted methodology that determines the association between reflux symptoms and reflux episodes, known as the symptom association probability or SAP. 7 The SAP divides each 24-hour study into 2-minute time periods. If a reflux episode occurs within 2 minutes of a reflux symptom, the 2-minute period is considered to be reflux-positive. We calculated a 2-minute period to be reflux-positive if a reflux event occurred within a 2-minute period before or during an episode of arrhythmia. We then counted the number of 2-minute periods during the study when reflux occurred, in the presence or absence of a concomitant arrhythmic event.
The third analysis was performed by counting the number of reflux and arrhythmic episodes that occurred during each hour of the study. We then created scatterplots and performed regression analysis to determine a potential relationship between the hourly frequency of arrhythmic and reflux events.
Statistical Analysis
We used 2004 Number Cruncher Statistical Systems Software 8 to perform categorical data analysis with Fisher exact test, scatterplot formation, and linear or multiple regression analysis. The level of significance for all tests was set at P<0.05.
CASE SERIES Case 1
A 65-year-old woman with frequent, paroxysmal atrial fibrillation for 10 years, presented with increasing frequency of weekly palpitations. The patient also reported a 30-year history of acid-regurgitation and was unable to tolerate a variety of medications prescribed for atrial fibrillation due to worsening of her gastroesophageal reflux symptoms. A 24-hour ambulatory esophageal pH study demonstrated bipositional pathologic reflux with a fraction time that the pH<4.0 of 13% with 12.5% in the upright position, and 15.4% in the supine position. There were 111 reflux episodes occurring over a period of 192 minutes. A simultaneous Holter monitor demonstrated 6 episodes of atrial fibrillation occurring over 497 minutes. Figure  1A graphically illustrates the potential correlation between acidreflux and episodes of atrial fibrillation in this patient. This correlation seemed significant when analysis was performed for the total number of events and the duration of reflux and arrhythmic events (Tables 1, 2 ). Linear regression analysis, shown in Figure 2 , showed a significant correlation for both events during the 24-hour period (r 2 = 0.42, P = 0.0006). The patient's reflux and arrhythmia symptoms as well as the frequency of both acid reflux events and arrhythmia improved dramatically on twice daily omeprazole 20 mg, as documented by repeat pH and Holter monitoring on antireflux therapy (Fig. 1B) . During the second pH study there were no documented episodes of reflux, and the Holter study demonstrated atrial fibrillation occurring over a period of 12 minutes. Because she remained partly symptomatic with reflux symptoms despite twice daily PPI therapy, the patient elected to undergo laparoscopic antireflux surgery. Although the patient's atrial fibrillation was difficult to control pre-Nissen fundoplication, her atrial arrhythmia remained under good control postoperatively on once-daily verapamil therapy.
Case 2
A 46-year-old Asian male first noted onset of intermittent palpitations 5 years before presentation that progressed to occur on a daily basis. The patient also reported acid regurgitation twice a week. The patient underwent simultaneous Holter and 24-hour ambulatory esophageal pH monitoring. The Holter tracing revealed 11 episodes of atrial flutter and fibrillation lasting a total of 7 minutes. Ambulatory esophageal pH study demonstrated mild, primarily supine pathologic gastro-esophageal reflux with a fraction time with pH<4.0 of 4.3%, with 2.9% in the upright position and 5.2% in the supine position. There were 14 asymptomatic reflux episodes that occurred over a period of 54.6 minutes. The correlation between the total time of reflux and arrhythmic events and the number of events is shown in Table 1 . Although the patient was a nocturnal refluxer, none of the arrhythmic events occurred at night. There seemed to be correlation between the number of reflux and arrhythmic events using analyses for total time and the symptom associated probability (Table 2) . However, linear regression analysis did not show a significant association (r 2 = 0.05, P = 0.3). The patient was then placed on omeprazole 20 mg daily and experienced complete resolution of his reflux symptoms and palpitations. He declined a repeat pH and Holter study on PPI therapy. One year later, the patient felt well on PPI therapy and reported that his palpitations would recur if he missed several days of omeprazole therapy.
Case 3
A 55-year-old white female first noted palpitations at age 44 which decreased in frequency after treatment with atenolol. A Holter monitor demonstrated the presence of intermittent atrial fibrillation. The patient also complained of long-standing heartburn and daily acid regurgitation. A 24-hour esophageal pH monitoring study demonstrated severe bipositional reflux with 136 reflux episodes and the fraction of time with pH<4.0 of 35.7%, with 32.7% in the upright position, and 40.7% in the supine position. A simultaneous Holter monitor demonstrated 6 episodes of atrial flutter that occurred for approximately 10 seconds each; however, the data recording mechanism failed after an initial 6 hours of Holter recording. Correlation between the 36-reflux episodes that occurred during the 6-hour Holter recording period and the arrhythmic events was found to be highly significant (Tables 1, 2) . Multiple logistic regression analysis for hourly episodes of arrhythmia and reflux almost reached statistical significance (P = 0.07). Because of persistent symptoms, a repeat pH study on lansoprazole 30 mg twice daily demonstrated no improvement in acid control with a fraction pH<4.0 of 39%. Repeat Holter monitoring on PPI therapy was not performed. Radiofrequency application to the lower esophageal sphincter (Stretta) was applied with subjective decrease in GERD symptoms and palpitations but repeat pH and Holter testing were not performed after the radiofrequency application. The patient continues to have reported intermittent but less frequent palpitations.
DISCUSSION
GERD and atrial arrhythmias are 2 common diseases in the United States. Although it is not uncommon that patients may experience palpitations and symptoms of gastroesophageal reflux, our case series suggests a potential causal relationship between gastroesophageal reflux and atrial arrhythmias. This relationship is supported by simultaneous Holter and 24-hour esophageal pH monitoring demonstrating a temporal correlation between the 2 processes occurring more than would be expected by chance alone (Tables 1, 2 ). This correlation was significant for the total time of coordinated events in all 3 patients, and the association using the SAP methodology in 2 of the 3 patients.
In all patients, both the frequency of reflux and arrhythmic events as well as the associated symptoms decreased subjectively on antireflux therapy. This was documented by a repeat pH and Holter study in the first patient (Fig. 1 ). Prospective studies with repeat pH and simultaneous Holter monitoring studies performed on PPI therapy are necessary to document whether a clinically significant change in symptoms and arrhythmic events would occur on antireflux therapy. A prior study published in 2003 assessed whether PPI therapy for GERD symptoms in patients with lone atrial fibrillation (PAF) lead to a reduction in PAF-related symptoms. 4 Eighteen patients who had documented reflux esophagitis by upper endoscopic examination and evidence of PAF (documented by at least 2 episodes of atrial fibrillation alternating with sinus rhythm documented by electrocardiography within 3 months before upper endoscopy) were included. After 2 months of PPI therapy, decrease or disappearance of at least 1 PAF-related symptom occurred in 14/18 (78%) of the patients. Antiarrhythmic drugs were discontinued in 5 (28%) of the patients. The strengths of this current case series are that 24-hour pH and Holter monitoring were used, allowing for more detailed quantification and comparison of reflux and arrhythmic events. In addition, the current series demonstrates a relationship between GERD and atrial arrhythmias in patients with nonerosive GERD.
The exact mechanism(s) for this potential relationship between acid reflux and atrial arrhythmias have not been previously explored. The main mechanism for acid reflux in patients with GERD seems to be an increased frequency of transient lower esophageal sphincter relaxations that result from a vagally mediated reflex with sensory signals originating from the esophagus and gastric cardia. 9 In patients with cardiac arrhythmias and heart disease, both vagal and sympathetic factors are thought to contribute to the onset of the arrhythmia. In the absence of heart disease, however, vagal factors are more likely to be responsible for the onset of arrhythmias. 10 Increased vagal tone that might precipitate the onset of tachycardia has been associated with the postprandial state, cough, nausea, and ingestion of cold food or liquids. 11 In patients who experience both arrhythmias and acid reflux, it is possible that the same event, such as the postprandial state, triggers simultaneous symptoms via the parasympathetic pathway.
In summary, our case series suggests a potential relationship between atrial arrhythmias and acid reflux events that is substantiated by simultaneous 24-hour pH and Holter monitoring. Until further prospective, large-scale studies confirm such association, clinicians should inquire about this constellation of cardiac and esophageal symptoms and consider dual Holter and pH monitoring when evaluating a patient with palpitations and symptomatic GERD. Patients with documentation of both atrial arrhythamis and reflux should have a trial of aggressive acid suppressive therapy. Future studies should assess whether maximal acid suppression improves atrial arrhythmias. 
FIGURE 2.
Linear regression analysis for the first patient. The number of arrhythmic events per hour are plotted on the y-axis, and the number of reflux episodes per hour on the x-axis. The plot demonstrates a significant correlation between hourly episodes of arrhythmia and reflux (P = 0.0006).
